Iodixanol in Multidetector-Row Computed Tomography-Coronary Angiography (MDCT-CA)
Phase 4
Completed
- Conditions
- Coronary Artery Disease
- Registration Number
- NCT00209404
- Lead Sponsor
- GE Healthcare
- Brief Summary
Image quality in coronary artery computed tomography is influenced by the heart rate variation during the examination. The purpose of this clinical trial is to investigate the change in heart rate following injection of a contrast medium called Visipaque™ (iodixanol). Image quality and diagnostic quality of the examination will be evaluated.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- Subjects with low to moderate suspicion of coronary artery disease referred for retrospective electrocardiogram (ECG)-gated multidetector row computed tomography coronary angiography and with a heart rate >75 beats per minute (bpm) will be included.
Exclusion Criteria
- Subjects who take medications that slow down the heart rate or present cardiac arrhythmia at rest will not be included.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Change in mean heart rate
- Secondary Outcome Measures
Name Time Method Image quality Diagnostic quality Overall diagnostic information Frequency and intensity of adverse events
Trial Locations
- Locations (1)
Amersham Health S.A.
🇫🇷Velizy Cedex, France